#1
|
||||
|
||||
MRSA Often Found on Stethoscopes of Emergency Medical Personnel
MRSA Often Found on Stethoscopes of Emergency Medical Personnel
Ïîäðîáíåå çäåñü: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] (íóæíî ïðîéòè êðàòêóþ ïðîöåäóðó ðåãèñòðàöèè). "NEW YORK (Reuters Health) Mar 17 - The results of a small study at one tertiary care center suggest that roughly one in three stethoscopes carried by emergency medical service (EMS) professionals harbor methicillin-resistant Staphylococcus aureus (MRSA)...."  Ìîñêâå - ìîæíî ïðîâåðèòü ñâîé ôîíåíäîñêîï (èëè ðó÷êó, êîìïüþòåðíóþ ìûøêó è ò.ï.) âñåãî çà 150 ðóá. Ìîãó ïîäñêàçàòü òåëåôîí÷èê Ìû íåäàâíî ïîïðîñèëè ñäåëàòü ñìûâû ñ ïîäîáíûõ ïðåäìåòîâ â íàøåì àìáóëàòîðíîì êàáèíåòå "Äèàáåòè÷åñêàÿ ñòîïà". Ïðàâäà, ïîëó÷èëèñü íåïëîõèå ðåçóëüòàòû: èç 10 ñìûâîâ ëèøü â 2-õ - ñàïðîôèòíûå ñòàôèëëîêîêêè. |
#2
|
|||
|
|||
ß âñåãäà îáðàáàòûâàþ "ýêîáðèçîì" ìåæäó ïàöèåíòàìè .. íå çíàþ íàñêîëüêî ýòî ýôôåêòèâíî, ïðàâäà.
|
#3
|
|||
|
|||
Ðåçàòü, âìåñòå ñ ãàëñòóêàìè
ïðîòèðàéòå ýòèëîâûì ñïèðòîì 70* è íå íàäî ïëàòèòü ñòîïèñÿò ðóáëåé. |
#4
|
|||
|
|||
À "ýêîáðèç" ìåíåå ýôôåêòèâåí ÷òî ëè ? Ïðîñòî ó íàñ åãî ñòàíäàðòíî èñïîëüçóþò - îí íà êàæäîé êðîâàòè ôèêñèðîâàí è â óäîáíîé ïëàñòèêîâîé óïàêîâêå.
|
#5
|
||||
|
||||
ýýý...ñîððè ÷òî íåìíîãî â ñòîðîíó âîïðîñ - èç íîñà ïîñåâû ó ïåðñîíàëà íàñêîëüêî îáîñíîâàíû? ó íåêîòîðûõ ðàñòåò ñòàôèëîêîêê è îíè ñ ïîçîðîì îòïðàâëÿþòñÿ êàïàòü â íîñ õëîðîôèëëèïò èëè åùå êàêóþ òî äðÿíü...
Ýïèäåìèîëîãó (ìèêðîîíèùåíêî) îáúÿñíÿòü áåñïîëåçíî, íà÷àëüñòâî âíèêàòü íå õî÷åò...åñòü êàêèå ïðèêàçû? âîîáùå íàñêîëüêî ýòî EBM? ìîæåò è ïðàâäà òàê íàäî (íó áåç õëîðîôèëëèïòà òàì...) |
#6
|
|||
|
|||
Âñÿêóþ äðÿíü ñ çàâèäíûì ïîñòîÿíñòâîì íàõîäÿò â ñàìûõ íåîæèäàííûõ ìåñòàõ
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#7
|
||||
|
||||
#8
|
|||
|
|||
Âèäîâ ýêîáðèçîâ íåñêîëüêî - ñïðåé, ãåëü, äëÿ ìåñòà îïåðàöèè è ïðîñòî àíòèñåïòèê. Äëÿ ãèãèåíè÷åñêîé îáðàáîòêè ðóê ðåêîìåíäóåòñÿ ýêñïîçèöèÿ 1 ìèíóòà. Ñðåäñòâî îáëàäàåò àêòèâíîñòüþ â îòíîøåíèè ãðàìïîëîæèòåëüíûõ (âêëþ÷àÿ ìèêîáàêòåðèè òóáåðêóëåçà) è ãðàìîòðèöàòåëüíûõ áàêòåðèé, âèðóñîâ (ãåïàòèò Â, ÂÈ×), äðîææåïîäîáíûõ ãðèáîâ ðîäà Êàíäèäà. Òàê ÷òî â îòíîøåíèè ñòàôèëîêîêêà - íîðìàëüíûé âûáîð.
|
#9
|
|||
|
|||
Öèòàòà:
Ýòî äåéñòâî áûëî ðåãëàìåíòèðîâàíî ïðèêàçîì ÌÇ ÑÑÑÐ ¹ 720 îò 31 èþëÿ 1978 ãîäà ï 1.16. Çàâåäóþùèé îòäåëåíèåì îäèí ðàç â êâàðòàë îðãàíèçóåò îáñëåäîâàíèå îáñëóæèâàþùåãî ïåðñîíàëà íà íîñèòåëüñòâî ïàòîãåííîãî ñòàôèëîêîêêà è â ñëó÷àå âûÿâëåíèÿ íîñèòåëåé îðãàíèçóåò ïðîâåäåíèå ñàíàöèè èõ. ï 1.17. Ïðè âîçíèêíîâåíèè âíóòðèáîëüíè÷íûõ èíôåêöèé ñðåäè áîëüíûõ ïðîâîäÿò âíåî÷åðåäíîé ìåäèöèíñêèé îñìîòð âñåãî ïåðñîíàëà îòäåëåíèÿ, à òàêæå âíåî÷åðåäíîå áàêòåðèîëîãè÷åñêîå îáñëåäîâàíèå íà íîñèòåëüñòâî.  90-õ ãîäàõ ñóùåñòâîâàëà ñîâìåñòíàÿ ñ àìåðèêàíöàìè ïàðòíåðñêàÿ ïðîãðàììà "Èíôåêöèîííûé êîíòðîëü", êîòîðàÿ ïðèâíåñëà ìíîãî ñîâðåìåííîãî â Ðîññèþ, íî ïî îêîí÷àíèè ôèíàíñèðîâàíèÿ íàøèìè íå ñòàëà ïîääåðæèâàòüñÿ è áëàãîïîëó÷íî çàãíóëàñü ãäå-òî ê 2000 ãîäó. ìíîãî ãîâîðèëîñü îá ýòîì èññëåäîâàíèè íîñà-çåâà íà âñåõ óðîíÿõ, ïðèçíàâàëîñü. ÷òî ýòî óñòàðåëî, íåàäåêâàòíî, çàòðàòíî è òï.  ýòîò ïåðèîä ïëàíîâîå îáñëåäîâàíèå íîñà-çåâà ïåðñîíàëà ó÷ðåæäåíèé îòìåíèëè Ïðèêàçîì îò 1997 ãîäà "Î ñîâåðøåíñòâîâàíèè ìåðîïðèÿòèé ïî ïðîôèëàêòèêå âíóòðèáîëüíè÷íûõ èíôåêöèé â àêóøåðñêèõ ñòàöèîíàðàõ", îñòàâèâ òîëüêî ïî ýïèäïîêàçàíèÿì, êàê è âî âñåì ìèðå. Íî ñ õèðóðãè÷åñêî-àíåñòåçèîëîãè÷åñêîé ñëóæáîé ýòîãî íå ñëó÷èëîñü, Ïðèêàç 720 æèâ äî ñèõ ïîð. Íà ñëîâàõ âûñîêèå ÷èíû ñàíèòàðíîé ñëóæáû è ïðîôåññóðà (è àäåêâàòíûå ðåãèîíàëüíûå ÷èíîâíèêè) ïðèçíàþò, ÷òî ýòî íå äîëæíî ïðîèçâîäèòüñÿ, à íà äåëå ïî ðàçíîìó... Âî ìíîãèõ ðåãèîíàõ ñâÿòî ÷òóò ýòîò 720 ïðèêàç è äî ñèõ ïîð îáñëåäóþò íàðîä åæåêâàðòàëüíî, òðàòÿ àööêèå äåíüãè. Îñîáåííî åñëè íåò ñâîåé áàêëàáîðàòîðèè, òî çà ýòî íàäî ïëàòèòü áàêëàáîðàòîðèè Ðîñïîòðåáíàäçîðà, à îíè è ðàäû.  íåêîòîðûõ ðåãèîíàõ ýòî îòìåíèëè, íî íà ñâîé ñòðàõ è ðèñê. |
#10
|
|||
|
|||
 Ìîñêâå âîîáùå ÷óäåñ ìíîãî, ïðàâàÿ ðóêà íå çíàåò ïðî ëåâóþ, òî åñòü ðóêîâîäñòâî Ðîñïîòðåáíàäçîðà äåêëàðèðóåò îäíî, à ìíîãèå ñïåöèàëèñòû ðàéîííûõ ñàíýïèäñòàíöèé òðåáóþò ïî ñòàðèíêå è ñ íèìè ñïîðèòü áîÿòñÿ.
Åñòü Ïîñòàíîâëåíèå Ïðàâèòåëüñòâà Ìîñêâû îò 28 äåêàáðÿ 1999 ã. N 1228 "Îá îáÿçàòåëüíûõ ïðîôèëàêòè÷åñêèõ ìåäèöèíñêèõ îñìîòðàõ è ãèãèåíè÷åñêîé àòòåñòàöèè" Ïåðå÷åíü ïðîôåññèé, ïðîèçâîäñòâ, ïðåäïðèÿòèé, ó÷ðåæäåíèé è îðãàíèçàöèé íåçàâèñèìî îò èõ îðãàíèçàöèîííî-ïðàâîâîé ôîðìû, ðàáîòíèêè êîòîðûõ ïðîõîäÿò îáÿçàòåëüíûå ïðåäâàðèòåëüíûå (ïðè ïîñòóïëåíèè íà ðàáîòó) è ïåðèîäè÷åñêèå ìåäèöèíñêèå îñìîòðû è ãèãèåíè÷åñêóþ àòòåñòàöèþ ... 1. Ðàáîòíèêè ïðåäïðèÿòèé òîðãîâëè ïðîäîâîëüñòâåííûìè òîâàðàìè è èçäåëèÿìè, ïðåäíàçíà÷åííûìè äëÿ êîíòàêòà ñ ïðîäóêòàìè ïèòàíèÿ è âîäîé, ïðîäîâîëüñòâåííûõ îïòîâûõ ðûíêîâ. 2. Ðàáîòíèêè òîðãîâëè ïðîìûøëåííûìè òîâàðàìè äëÿ äåòåé, ïàðôþìåðíî-êîñìåòè÷åñêèìè èçäåëèÿìè. 3. Ðàáîòíèêè òîðãîâëè ïðîìûøëåííûìè òîâàðàìè, â ò.÷. âåùåâûõ ðûíêîâ. 4. Ðàáîòíèêè ïðåäïðèÿòèé îáùåñòâåííîãî ïèòàíèÿ, áóôåòîâ, êèîñêîâ, ïèùåáëîêîâ âñåõ ó÷ðåæäåíèé è îðãàíèçàöèé. 5. Ðàáîòíèêè êðåìîâî-êîíäèòåðñêèõ öåõîâ, ïðîèçâîäñòâ, äåòñêèõ ìîëî÷íûõ êóõîíü. 6. Ðàáîòíèêè ïðåäïðèÿòèé ïèùåâûõ îòðàñëåé ïðîìûøëåííîñòè, áàç è ñêëàäîâ äëÿ õðàíåíèÿ è ðåàëèçàöèè ïðîäîâîëüñòâåííûõ òîâàðîâ. 7. Ðàáîòíèêè òðàíñïîðòíûõ ïðåäïðèÿòèé è ÷àñòíûå ëèöà, çàíÿòûå ïåðåâîçêîé ïðîäîâîëüñòâåííûõ òîâàðîâ íà âñåõ âèäàõ òðàíñïîðòà (àâòîìîáèëüíûé, æåëåçíîäîðîæíûé, àâèàòðàíñïîðò, ðå÷íîé è ìîðñêîé òðàíñïîðò). 8. Âîäèòåëè òðàíñïîðòíûõ ïðåäïðèÿòèé è ÷àñòíûå ëèöà, çàíÿòûå ïåðåâîçêîé ëþäåé (òàêñè, ãîðîäñêîé ïàññàæèðñêèé òðàíñïîðò), à òàêæå âîäèòåëè ìåæäóãîðîäíûõ ïåðåâîçîê íåçàâèñèìî îò ôîðì ñîáñòâåííîñòè è âåäîìñòâåííîé ïðèíàäëåæíîñòè. 9. Ïðîâîäíèêè ïàññàæèðñêèõ ïîåçäîâ äàëüíåãî ñëåäîâàíèÿ, ðå÷íîãî, ìîðñêîãî è àâèàòðàíñïîðòà. 10. Ðàáîòíèêè ó÷åáíî-âîñïèòàòåëüíûõ ó÷ðåæäåíèé (îáùåîáðàçîâàòåëüíûå øêîëû, äåòñêèå äîìà, ïðîôåññèîíàëüíî-òåõíè÷åñêèå ó÷èëèùà, òåõíèêóìû, øêîëû-èíòåðíàòû, ëèöåè, êîëëåäæè). 11. Ðàáîòíèêè ñåçîííûõ äåòñêèõ è ïîäðîñòêîâûõ îçäîðîâèòåëüíûõ ó÷ðåæäåíèé (ïåðåä íà÷àëîì ðàáîòû). 12. Ðàáîòíèêè äåòñêèõ äîøêîëüíûõ ó÷ðåæäåíèé (ÿñëè, ñàäû, äîìà ðåáåíêà, øêîëû-èíòåðíàòû, äåòñêèå ñàíàòîðíûå êðóãëîãîäè÷íûå îçäîðîâèòåëüíûå ó÷ðåæäåíèÿ). 13. Ìåäèöèíñêèå ðàáîòíèêè ðîäèëüíûõ äîìîâ (îòäåëåíèé), äåòñêèõ áîëüíèö (îòäåëåíèé), îòäåëåíèé ïàòîëîãèè íîâîðîæäåííûõ, îòäåëåíèé äëÿ íåäîíîøåííûõ. 14. Ìåäèöèíñêèå ðàáîòíèêè ëå÷åáíî-ïðîôèëàêòè÷åñêèõ ó÷ðåæäåíèé, ñàíàòîðèåâ, äîìîâ îòäûõà, ïàíñèîíàòîâ, èíòåðíàòîâ è äîìîâ äëÿ èíâàëèäîâ è ïðåñòàðåëûõ, à òàêæå íàó÷íûå ñîòðóäíèêè ó÷ðåæäåíèé çäðàâîîõðàíåíèÿ è ëàáîðàòîðèé, íåïîñðåäñòâåííî ðàáîòàþùèå ñ ïàöèåíòàìè èëè áèîëîãè÷åñêèìè ìàòåðèàëàìè. Ïåðå÷åíü è êðàòíîñòü ïðîõîæäåíèÿ îáÿçàòåëüíûõ ïðåäâàðèòåëüíûõ (ïðè ïîñòóïëåíèè íà ðàáîòó) è ïåðèîäè÷åñêèõ ìåäèöèíñêèõ îñìîòðîâ ðàáîòíèêîâ äåêðåòèðîâàííûõ ïðîôåññèé 1. Ïðåäâàðèòåëüíûå (ïðè ïîñòóïëåíèè íà ðàáîòó) ìåäèöèíñêèå îñìîòðû ðàáîòíèêîâ, ïåðå÷èñëåííûõ â ïðèëîæåíèè 1, âêëþ÷àþò îñìîòð òåðàïåâòîì è äåðìàòîâåíåðîëîãîì, èññëåäîâàíèå êðîâè íà ñèôèëèñ, áàêòåðèîñêîïè÷åñêîå èññëåäîâàíèå íà ãîíîðåþ è òðèõîìîíèàç, ôëþîðîãðàôè÷åñêîå îáñëåäîâàíèå îðãàíîâ ãðóäíîé êëåòêè. 1.1. Äîïîëíèòåëüíî ðàáîòíèêè, ïåðå÷èñëåííûå â ïðèëîæåíèè 1: óêàçàííûå â ïóíêòàõ 1, 4-7, 12, 15, 20, 22 ïðîõîäÿò îáñëåäîâàíèå íà êèøå÷íóþ ãðóïïó èíôåêöèé; óêàçàííûå â ïóíêòàõ 5, 10 (òîëüêî äëÿ êðåìîâî-êîíäèòåðñêèõ öåõîâ è äåòñêèõ ìîëî÷íûõ êóõîíü) ïðîõîäÿò îñìîòð ó ñòîìàòîëîãà, îòîëàðèíãîëîãà è èññëåäîâàíèå ìàçêà èç íîñîãëîòêè íà ñòàôèëîêîêê; óêàçàííûå â ïóíêòå 13 ïðîõîäÿò îñìîòð ó ñòîìàòîëîãà, îòîëàðèíãîëîãà, èññëåäîâàíèå êðîâè íà ÂÈ× è âèðóñíûå ãåïàòèòû  è Ñ; óêàçàííûå â ïóíêòå 14 (âðà÷è, ñðåäíèé è ìëàäøèé ìåäèöèíñêèé ïåðñîíàë, íàó÷íûå ñîòðóäíèêè ó÷ðåæäåíèé çäðàâîîõðàíåíèÿ è ëàáîðàòîðèé, íåïîñðåäñòâåííî ðàáîòàþùèå ñ ëèöàìè èëè áèîëîãè÷åñêèìè ìàòåðèàëàìè, èíôèöèðîâàííûìè ÂÈ×, èëè èçãîòàâëèâàþùèå ìåäèöèíñêèå èììóíîáèîëîãè÷åñêèå ïðåïàðàòû), ïðîõîäÿò îáñëåäîâàíèå íà ÂÈ×-èíôåêöèþ. 2. Ïåðèîäè÷åñêèå ìåäèöèíñêèå îñìîòðû ïðåäóñìàòðèâàþò ñëåäóþùèå: 2.1. îñìîòð äåðìàòîâåíåðîëîãîì, èññëåäîâàíèå êðîâè íà ñèôèëèñ è áàêòåðèîñêîïè÷åñêîå èññëåäîâàíèå íà ãîíîðåþ è òðèõîìîíèàç: îäèí ðàç â ãîä - ó ðàáîòíèêîâ, ïåðå÷èñëåííûõ â ïóíêòàõ 2, 3, 8, 10, 19 ïðèëîæåíèÿ 1; äâà ðàçà â ãîä - ó ðàáîòíèêîâ, ïåðå÷èñëåííûõ â ïóíêòàõ 1, 4-7, 9, 14-18 ïðèëîæåíèÿ 1; ÷åòûðå ðàçà â ãîä - ó ðàáîòíèêîâ, ïåðå÷èñëåííûõ â ïóíêòàõ 12, 13 ïðèëîæåíèÿ 1; 2.2. îñìîòð òåðàïåâòîì è ôëþîðîãðàôè÷åñêîå îáñëåäîâàíèå ãðóäíîé êëåòêè îäèí ðàç â ãîä - ó ðàáîòíèêîâ, ïåðå÷èñëåííûõ â ïðèëîæåíèè 1, êðîìå ïóíêòà 11; 2.3. îñìîòð ñòîìàòîëîãîì, îòîëàðèíãîëîãîì, äåðìàòîâåíåðîëîãîì ïðîâîäèòü äâà ðàçà â ãîä ðàáîòíèêàì, ïåðå÷èñëåííûì â ïóíêòå 13 ïðèëîæåíèÿ 1; 2.4. îáñëåäîâàíèå íà ÂÈ×-èíôåêöèþ ïðîâîäèòñÿ äâà ðàçà â ãîä ó ìåäèöèíñêèõ ðàáîòíèêîâ ó÷ðåæäåíèé ðîäîâñïîìîæåíèÿ, îáñëóæèâàþùèõ ÂÈ×-èíôèöèðîâàííûõ æåíùèí, è ó ðàáîòíèêîâ, ïåðå÷èñëåííûõ â ïóíêòå 13 ïðèëîæåíèÿ 1. 2.5. áàêòåðèîëîãè÷åñêîå èññëåäîâàíèå íà ãîíîðåþ è òðèõîìîíèàç ïðîâîäèòñÿ 2 ðàçà â ãîä ðàáîòíèêàì, ïåðå÷èñëåííûì â ïóíêòå 13 ïðèëîæåíèÿ 1. Òî åñòü, êàê ìû âèäèì, Ïðàâèòåëüñòâî ìîñêâû äëÿ ìîñêîâñêèõ ìåäèêîâ ïëàíîâîãî îáñëåäîâàíèÿ íå ðåãëàìåíòèðóåò. ×òî ó âîåííûõ, ÿ íå çíàþ. Ìîæåò áûòü îíè äî ñèõ ïîð ïîëüçóþòñÿ òðåáîâàíèÿìè 720 ïðèêàçà |
#11
|
|||
|
|||
Êñòàòè, ñ ìàÿ 2009 ãîäà âñòóïàþò â äåéñòâèå íîâûå Ñàíèòàðíûå ïðàâèëà ÏÐÎÔÈËÀÊÒÈÊÀ ÂÍÓÒÐÈÁÎËÜÍÈ×ÍÛÕ ÈÍÔÅÊÖÈÉ Â ÑÒÀÖÈÎÍÀÐÀÕ (ÎÒÄÅËÅÍÈßÕ)
ÕÈÐÓÐÃÈ×ÅÑÊÎÃÎ ÏÐÎÔÈËß ËÅ×ÅÁÍÛÕ ÎÐÃÀÍÈÇÀÖÈÉ ñì ïóíêò 2.11 "Ïëàíîâîå îáñëåäîâàíèå ìåäèöèíñêîãî ïåðñîíàëà õèðóðãè÷åñêèõ ñòàöèîíàðîâ (îòäåëåíèé) íà íîñèòåëüñòâî çîëîòèñòîãî ñòàôèëîêîêêà íå ïðîâîäÿò." http://forums.rusmedserv.com/showthread.php?t=84710 |
#12
|
|||
|
|||
Êñòàòè, â íåäàâíåì JAMA:
Methicillin-Resistant Staphylococcus aureus Central Line–Associated Bloodstream Infections in US Intensive Care Units, 1997-2007 Context Concerns about rates of methicillin-resistant Staphylococcus aureus (MRSA) health care–associated infections have prompted calls for mandatory screening or reporting in efforts to reduce MRSA infections. Objective To examine trends in the incidence of MRSA central line–associated bloodstream infections (BSIs) in US intensive care units (ICUs). Design, Setting, and Participants Data reported by hospitals to the Centers for Disease Control and Prevention (CDC) from 1997-2007 were used to calculate pooled mean annual central line–associated BSI incidence rates for 7 types of adult and nonneonatal pediatric ICUs. Percent MRSA was defined as the proportion of S aureus central line–associated BSIs that were MRSA. We used regression modeling to estimate percent changes in central line–associated BSI metrics over the analysis period. Main Outcome Measures Incidence rate of central line–associated BSIs per 1000 central line days; percent MRSA among S aureus central line–associated BSIs. Results Overall, 33 587 central line–associated BSIs were reported from 1684 ICUs representing 16 225 498 patient-days of surveillance; 2498 reported central line–associated BSIs (7.4%) were MRSA and 1590 (4.7%) were methicillin-susceptible S aureus (MSSA). Of evaluated ICU types, surgical, nonteaching-affiliated medical-surgical, cardiothoracic, and coronary units experienced increases in MRSA central line–associated BSI incidence in the 1997-2001 period; however, medical, teaching-affiliated medicalsurgical, and pediatric units experienced no significant changes. From 2001 through 2007, MRSA central line–associated BSI incidence declined significantly in all ICU types except in pediatric units, for which incidence rates remained static. Declines in MRSA central line– associated BSI incidence ranged from −51.5% (95% CI, −33.7% to −64.6%; P.001) in nonteaching-affiliated medical-surgical ICUs (0.31 vs 0.15 per 1000 central line days) to −69.2% (95% CI, −57.9% to −77.7%; P.001) in surgical ICUs (0.58 vs 0.18 per 1000 central line days). In all ICU types, MSSA central line–associated BSI incidence declined from 1997 through 2007, with changes in incidence ranging from −60.1% (95% CI, −41.2% to −73.1%; P.001) in surgical ICUs (0.24 vs 0.10 per 1000 central line days) to −77.7% (95% CI, −68.2% to −84.4%; P.001) in medical ICUs (0.40 vs 0.09 per 1000 central line days). Although the overall proportion of S aureus central line–associated BSIs due to MRSA increased 25.8% (P=.02) in the 1997-2007 period, overall MRSA central line–associated BSI incidence decreased 49.6% (P.001) over this period. Conclusions The incidence of MRSA central line–associated BSI has been decreasing in recent years in most ICU types reporting to the CDC. These trends are not apparent when only percent MRSA is monitored. JAMA. 2009;301(7):727-736 Êîìó íóæåí fulltext - îáðàùàéòåñü â ëè÷êó. |